NCT01381497View on ClinicalTrials.gov

Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Migraine Disorders
Interventions
DRUG

Combination therapy of sumatriptan and naproxen sodium (SumaRT/Nap)

This is an observational study and patients were prescribed this medication before study start

DRUG

Triptan monotherapy

This is an observational study and patients reported a previous triptan monotherapy prescription. Drugs of interested included naratriptan, sumatriptan, rizatriptan, frovatriptan, almotriptan, eletriptan, zolmitriptan

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01381497 - Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy | Biotech Hunter | Biotech Hunter